Faculty Profiles - SHIMABUKURO Michio

Papers - SHIMABUKURO Michio

Division display1 - 20 of about 422／ All the affair displays >>

Innate Immune System Regulated by Stimulator of Interferon Genes, a Cytosolic DNA Sensor, Regulates Endothelial Function

Pham PT, Bavuu O, Kim-Kaneyama JR, Lei XF, Yamamoto T, Otsuka K, Suto K, Kusunose K, Yagi S, Yamada H, Soeki T, Shimabukuro Michio, Barber GN, Sata M, Fukuda D

Journal of the American Heart Association e030084 2023.11

Relationship between evacuation after the Great East Japan Earthquake and new-onset hyperuricemia: A 7-year prospective longitudinal study of the Fukushima Health Management Survey

Honda K, Okazaki K, Tanaka K, Kobari E, Kazama S, Hashimoto S, Ohira T, Sakai A, Yasumura S, Maeda M, Yabe H, Hosoya M, Takahashi A, Harigane M, Nakano H, Hayashi F, Nagao M, Shimabukuro Michio, Ohto H, Kamiya K, Kazama JJ

PLoS One 18 ( 10 ) e0293459 2023.10

L-Arginine, Nitric Oxide, and Endothelial Dysfunction Underlying Atherosclerotic Cardiovascular Disease (ASCVD)

Shimabukuro Michio

Journal of Atherosclerosis and Thrombosis 30 ( 10 ) 1311 - 1312 2023.10（ ISSN:1340-3478 ）

【異所性脂肪と心血管病】腎周囲脂肪の臨床的意義　メタボリックシンドロームや慢性腎臓病との関連性

田辺隼人, 島袋充生

医学のあゆみ 287 ( 3 ) 214 - 218 2023.10

Impact of red blood cell distribution width-albumin ratio on prognosis of patients with CKD

Kimura H, Tanaka K, Saito H, Iwasaki T, Kazama S, Shimabukuro Michio, Asahi K, Watanabe T, Kazama JJ

Scientific Reports 13 ( 1 ) 15774 2023.9

MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker

Shimabukuro Michio

Journal of Atherosclerosis and Thrombosis 30 ( 8 ) 853 - 854 2023.8（ ISSN:1340-3478 ）

Impact of Lifestyle and Psychosocial Factors on the Incidence of Hepatobiliary Enzyme Abnormalities After the Great East Japan Earthquake: Seven-Year Follow-up of the Fukushima Health Management Survey

Takahashi A, Ohira T, Hayashi F, Yasumura S, Shimabukuro Michio, Sakai A, Maeda M, Yabe H, Hosoya M, Kazama JJ, Hashimoto K, Nakano H, Nagao M, Sato S, Okazaki K, Harigane M, Ohto H, Kamiya K, Ohira H

Disaster Medicine and Public Health Preparedness 17 e441 2023.7（ ISSN:1935-7893 ）

Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR)

Tanaka A, Shibata H, Imai T, Yoshida H, Miyazono M, Takahashi N, Fukuda D, Okada Y, Teragawa H, Suwa S, Kida K, Moroi M, Taguchi I, Toyoda S, Shimabukuro Michio, Tanabe K, Tanaka K, Nangaku M, Node K, FIVE-STAR trial investigators

Cardiovascular Diabetology 22 ( 1 ) 194 2023.7

Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA).

Tanaka A, Taguchi I, Hisauchi I, Yoshida H, Shimabukuro Michio, Hongo H, Ishikawa T, Kadokami T, Yagi S, Sata M, Node K, DIANA study investigators

European journal of medical research 28 ( 1 ) 238 2023.7（ ISSN:0949-2321 ）

Effect of ipragliflozin on endothelial dysfunction in patients with type 2 diabetes and chronic kidney disease: A randomized clinical trial (PROCEED)

Tanaka A, Okada Y, Torimoto K, Kamei N, Hirai H, Kono T, Sugimoto K, Teragawa H, Taguchi I, Maruhashi T, Sonoda S, Kurozumi A, Inagaki S, Oshita C, Hisauchi I, Takahashi K, Higashi Y, Shimabukuro Michio, Node K, PROCEED Trial Investigators

Diabetes & Metabolism 49 ( 4 ) 101447 2023.7（ ISSN:1262-3636 ）

【糖尿病診療における診療機器の活用】FMDの解釈と活用

島袋充生

糖尿病・内分泌代謝科 57 ( 1 ) 35 - 39 2023.7（ ISSN:2435-1946 ）

The Usefulness of Prioritization of Ivabradine Before Beta-Blockers in a Heart Failure Patient Suffering From Intra-hemodialysis Hypotension

Yamaguchi Satoshi, Nadoyama N, Kinjo K, Yagi N, Ishimori H, Shimabukuro Michio

Cureus 15 ( 6 ) e40609 2023.6（ ISSN:2168-8184 ）

【健康と疾患を制御する　精密栄養学「何を、いつ、どう食べるか?」に、食品機能の解析と個人差を生む分子メカニズムの解明から迫る】(第3章)精密栄養学の基盤となる食・栄養の分子作用メカニズム　玄米機能成分をめぐる脳科学と分子栄養学

益崎裕章, 岡本士毅, 島袋充生, 阿部啓子, 小塚智沙代

実験医学 41 ( 10 ) 1637 - 1643 2023.6（ ISSN:0288-5514 ）

Nonsteroidal Mineralocorticoid Receptor Antagonists and Protection Against Cardiovascular Disease in Patients with Diabetes Mellitus

Shimabukuro Michio

Journal of Atherosclerosis and Thrombosis 30 ( 4 ) 321 - 322 2023.4（ ISSN:1340-3478 ）

Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study

Kudo Akihiro, Machii Noritaka, Ono T, Saito Haruka, Oshiro Y, Takahashi R, Oshiro K, Taneda Y,　Higa M, Nakachi K, Yagi S, Masuzaki H, Sata M, Shimabukuro Michio

BMJ Open Diabetes Research & Care 11 ( 2 ) e003302 2023.4

糖尿病患者における非ステロイド性ミネラルコルチコイド受容体拮抗薬と心血管疾患予防(Nonsteroidal Mineralocorticoid Receptor Antagonists and Protection Against Cardiovascular Disease in Patients with Diabetes Mellitus)

Shimabukuro Michio

Journal of Atherosclerosis and Thrombosis 30 ( 4 ) 321 - 322 2023.4（ ISSN:1340-3478 ）

Association of polypharmacy with incidence of CKD: a retrospective cohort study

Kimura H, Tanaka K, Saito H, Iwasaki T, Watanabe S, Kazama S, Shimabukuro Michio, Asahi K, Watanabe T, Kazama JJ

Clinical and Experimental Nephrology 27 ( 3 ) 272 - 278 2023.3（ ISSN:1342-1751 ）

Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial.

Tanaka A, Sata M, Okada Y, Teragawa H, Eguchi K, Shimabukuro Michio, Taguchi I, Matsunaga K, Kanzaki Y, Yoshida H, Ishizu T, Ueda S, Kitakaze M, Murohara T, Node K, PROTECT study investigators

European Heart Journal. Cardiovascular Pharmacotherapy 9 ( 2 ) 165 - 172 2023.2（ ISSN:2055-6837 ）

Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trial

Yamaguchi Satoshi, Shimabukuro Michio, Tanaka A, Imai T, Hiramitsu S, Takahashi N, Kadokami T, Ajioka M, Suzuki M, Node K, CANDLE Trial Investigators

Diabetes, Obesity & Metabolism 25 ( 2 ) 354 - 364 2023.2（ ISSN:1462-8902 ）

Canagliflozin independently reduced plasma volume from conventional diuretics in patients with type 2 diabetes and chronic heart failure: a subanalysis of the CANDLE trial

Shiina K., Tomiyama H., Tanaka A., Imai T., Hisauchi I., Taguchi I., Sezai A., Toyoda S., Dohi K., Kamiya H., Kida K., Anzai T., Chikamori T., Node K., Ajioka M., Ako J., Amano R., Asai M., Eguchi K., Eshima K., Fujiki S., Fujita M., Hikoso S., Hiramitsu S., Hoshide S., Hoshino A., Ikeda Y., Ikehara Y., Inomata T., Inoue T., Ishii K., Ishizaka N., Ito M., Iwahashi N., Iwakura K., Kadokami T., Kanbara T., Kanzaki Y., Kashimura K., Kimura K., Kishi S., Kitada S., Kitakaze M., Kiyosue A., Kodama K., Kojima T., Kondo T., Kubota Y., Kusunose K., Machii N., Matsunaga K., Matsuo Y., Matsuzawa Y., Mikami T., Minamino T., Murohara T., Nagai T., Nagano Y., Nagumo M., Nakamura I., Nakamura K., Nakatani D., Nanasato M., Naruse H., Nishino M., Niwano S., Oguri M., Ohte N., Oikawa M., Okumura T., Okumura M., Onishi K., Oyama J.i., Ozaki Y., Saito K., Sakamoto T., Sakata Y., Sakuma M., Sata M., Sekino H., Shimabukuro M., Shimizu W., Suzuki M., Suzuki K., Takahama H., Takahashi N., Takeishi Y., Tamaki S., Tanaka A., Tanimoto S., Teragawa H., Tobushi T., Toita T., Tokuda K., Tsutsui H., Ueda S., Uehara H., Uematsu M., Watada H., Yahagi K.

Hypertension Research 46 ( 2 ) 495 - 506 2023.2（ ISSN:09169636 ）

　PREV- NEXT 　

<SHIMABUKURO Michio>

Papers - SHIMABUKURO Michio